Dipal Doshi Entrada Therapeutics, Inc. (TRDA) insider trading activity

TRDA Quotes by TradingView

Dipal Doshi is CEO of Entrada Therapeutics, Inc.. Currently has a direct ownership of 325,753 shares of TRDA, which is worth approximately $5.73 Million. The most recent transaction as insider was on Feb 28, 2023, when has been sold 2,000 shares (Common Stock) at a price of $12.0 per share, resulting in proceeds of $24,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 326K
0% 3M change
32.81% 12M change
Total Value Held $5.73 Million

Dipal Doshi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2023
SELL
Open market or private sale
$24,000 $12.0 p/Share
2,000 Reduced 1.22%
161,835 Common Stock
Jan 27 2023
SELL
Open market or private sale
$24,000 $12.0 p/Share
2,000 Reduced 1.21%
163,835 Common Stock
Jan 09 2023
SELL
Open market or private sale
$36,198 $15.02 p/Share
2,410 Reduced 1.43%
165,835 Common Stock
Dec 29 2022
SELL
Open market or private sale
$6,004 $15.01 p/Share
400 Reduced 0.24%
168,245 Common Stock
Dec 28 2022
SELL
Open market or private sale
$67,860 $15.01 p/Share
4,521 Reduced 2.61%
168,645 Common Stock
Dec 27 2022
SELL
Open market or private sale
$144,261 $14.92 p/Share
9,669 Reduced 5.29%
173,166 Common Stock
Nov 28 2022
SELL
Open market or private sale
$27,820 $13.91 p/Share
2,000 Reduced 1.08%
182,835 Common Stock
Oct 27 2022
SELL
Open market or private sale
$43,320 $21.66 p/Share
2,000 Reduced 1.07%
184,835 Common Stock
Oct 25 2022
SELL
Open market or private sale
$250,386 $20.76 p/Share
12,061 Reduced 6.06%
186,835 Common Stock
Oct 24 2022
SELL
Open market or private sale
$45,154 $19.28 p/Share
2,342 Reduced 1.16%
198,896 Common Stock
Oct 21 2022
SELL
Open market or private sale
$50,928 $18.28 p/Share
2,786 Reduced 1.37%
201,238 Common Stock
Oct 20 2022
SELL
Open market or private sale
$14,606 $18.01 p/Share
811 Reduced 0.4%
204,024 Common Stock
Sep 28 2022
SELL
Open market or private sale
$46,985 $15.23 p/Share
3,085 Reduced 1.48%
204,835 Common Stock
Sep 27 2022
SELL
Open market or private sale
$68,185 $15.43 p/Share
4,419 Reduced 2.08%
207,920 Common Stock
Sep 26 2022
SELL
Open market or private sale
$48,588 $15.76 p/Share
3,083 Reduced 1.43%
212,339 Common Stock
Sep 23 2022
SELL
Open market or private sale
$15,417 $15.07 p/Share
1,023 Reduced 0.47%
215,422 Common Stock
Sep 21 2022
SELL
Open market or private sale
$51,438 $15.12 p/Share
3,402 Reduced 1.55%
216,445 Common Stock
Sep 15 2022
SELL
Open market or private sale
$3,008 $15.04 p/Share
200 Reduced 0.09%
219,847 Common Stock
Sep 09 2022
SELL
Open market or private sale
$10,368 $15.07 p/Share
688 Reduced 0.31%
220,047 Common Stock
Sep 08 2022
SELL
Open market or private sale
$16,676 $15.16 p/Share
1,100 Reduced 0.5%
220,735 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
15,125 Added 6.38%
221,835 Common Stock
Aug 31 2022
SELL
Open market or private sale
$2,052 $12.0 p/Share
171 Reduced 0.08%
206,710 Common Stock
Aug 30 2022
SELL
Open market or private sale
$2,280 $12.0 p/Share
190 Reduced 0.09%
206,881 Common Stock
Aug 29 2022
SELL
Open market or private sale
$21,897 $13.36 p/Share
1,639 Reduced 0.79%
207,071 Common Stock
Jul 27 2022
SELL
Open market or private sale
$24,000 $12.0 p/Share
2,000 Reduced 0.95%
208,710 Common Stock
DD

Dipal Doshi

CEO
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRDA